The Company has built an impressive position in Duchenne muscular dystrophy DMD and in gene therapies for limbgirdle muscular dystrophies LGMDs mucopolysaccharidosis type IIIA CharcotMarieTooth CMT and other CNSrelated disorders with more than 40 programs in various stages of development